{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:41:16Z","timestamp":1795034476880,"version":"4.10.2"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["86923"],"award-info":[{"award-number":["86923"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["23015"],"award-info":[{"award-number":["23015"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Besides systemic drug delivery, the intranasal route of administration has\nshown potential for direct nose-to-brain drug delivery, which has gained popularity because it bypasses\nthe blood-brain barrier.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The region in the nose from which the epithelial tissue membrane is excised to conduct ex\nvivo permeation studies for nasal drug delivery studies may be of importance, but the permeability of\nthe epithelium from the different nasal regions has not yet been investigated in the sheep model.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>The permeation of five selected model compounds (i.e., atenolol, caffeine, Rhodamine 123,\nFITC-dextran, and Lucifer Yellow) was measured across epithelial tissues that were excised from two\ndifferent areas of the sheep nasal cavity, namely the ventral nasal concha (representing respiratory epithelium)\nand the ethmoid nasal concha (representing olfactory epithelium).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Although the selected compounds' permeation was generally slightly higher across the olfactory\nepithelial tissues than across the respiratory epithelial tissues, it was not statistically significant except\nin the case of atenolol.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The presence of olfactory nerves and supporting cells and the gaps between them in the\nolfactory epithelial tissues may have contributed to the higher permeation of atenolol, but this needs to\nbe further investigated to elucidate the precise mechanism.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201820666221214105836","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T14:06:03Z","timestamp":1671026763000},"page":"115-125","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["An Ex vivo Investigation on Drug Permeability of Sheep Nasal Epithelial\nTissue Membranes from the Respiratory and Olfactory Regions"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7416-1585","authenticated-orcid":true,"given":"Anja","family":"Haasbroek-Pheiffer","sequence":"first","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences (Pharmacen\u2122), Faculty of Health Sciences, North-West University,\nPotchefstroom-2520, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-2981","authenticated-orcid":true,"given":"Alvaro","family":"Viljoen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tshwane University of Technology, Private\nBag X680, Pretoria-0001, South Africa"},{"name":"SAMRC Herbal Drugs Research Unit, Tshwane University of Technology,\nPretoria-0001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4924-4423","authenticated-orcid":true,"given":"Jan","family":"Steenekamp","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences (Pharmacen\u2122), Faculty of Health Sciences, North-West University,\nPotchefstroom-2520, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tshwane University of Technology, Private\nBag X680, Pretoria-0001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8916-3927","authenticated-orcid":true,"given":"Josias","family":"Hamman","sequence":"additional","affiliation":[{"name":"Centre of Excellence for Pharmaceutical Sciences (Pharmacen\u2122), Faculty of Health Sciences, North-West University,\nPotchefstroom-2520, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/B978-0-12-817778-5.00009-9","author":"Alexander A.","year":"2020","unstructured":"Alexander A.; Agrawal M.; Chougule M.B.; Saraf S.; Saraf S.; Nose-to-brain drug delivery: An alternative approach for effective brain drug targeting. Nanopharmaceuticals: Expectations and Realities of Multifunctional Drug Delivery Systems 2020,175-200","journal-title":"Nanopharmaceuticals: Expectations and Realities of Multifunctional Drug Delivery Systems"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/pharmaceutics10020040","volume":"10","author":"Aderibigbe B.","year":"2018","unstructured":"Aderibigbe B.; In situ-based gels for nose to brain delivery for the treatment of neurological diseases. Pharmaceutics 2018,10(2),40","journal-title":"Pharmaceutics"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/156720112803529828","volume":"9","author":"Gizurarson S.","year":"2012","unstructured":"Gizurarson S.; Anatomical and histological factors affecting intranasal drug and vaccine delivery. Curr Drug Deliv 2012,9,566-582","journal-title":"Curr Drug Deliv"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2174\/1567201814666171013150534","volume":"15","author":"Patel A.A.","year":"2018","unstructured":"Patel A.A.; Patel R.J.; Patel S.R.; Nanomedicine for intranasal delivery to improve brain uptake. Curr Drug Deliv 2018,15(4),461-469","journal-title":"Curr Drug Deliv"},{"key":"ref=5","first-page":"237","author":"Sosnik A.","year":"2015","unstructured":"Sosnik A.; Tissue-based in vitro and ex vivo models for nasal permeability studies. Concepts and models for drug permeability studies 2015,237-254","journal-title":"Concepts and models for drug permeability studies"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1567201816666191029122740","volume":"16","author":"Kashyap K.","year":"2019","unstructured":"Kashyap K.; Shukla R.; Drug delivery and targeting to the brain through nasal route: Mechanisms, applications and challenges. Curr Drug Deliv 2019,16,887-901","journal-title":"Curr Drug Deliv"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2174\/1567201817666200708115627","volume":"18","author":"Shah P.","year":"2021","unstructured":"Shah P.; Sarolia J.; Vyas B.; Wagh P.; Ankur K.; Kumar M.A.; PLGA nanoparticles for nose to brain delivery of clonazepam: Formulation, optimization by 32 factorial design, in vitro and in vivo evaluation. Curr Drug Deliv 2021,18,805-824","journal-title":"Curr Drug Deliv"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425247.2013.790887","volume":"10","author":"Pardeshi C.V.","year":"2013","unstructured":"Pardeshi C.V.; Belgamwar V.S.; Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: An excellent platform for brain targeting. Expert Opin Drug Deliv 2013,10(7),957-972","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuropharm.2018.06.006","volume":"145","author":"Guennoun R.","year":"2019","unstructured":"Guennoun R.; Fr\u00e9chou M.; Gaignard P.; Liere P.; Slama A.; Schumacher M.; Denier C.; Mattern C.; Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries. Neuropharmacology 2019,145((Pt B)),283-291","journal-title":"Neuropharmacology"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.2174\/1567201818666210510173524","volume":"18","author":"Gautam D.","year":"2021","unstructured":"Gautam D.; Singh S.; Maurya P.; Singh M.; Kushwaha S.; Saraf S.A.; Appraisal of nano-lipidic astaxanthin cum thermoreversible gel and its efficacy in haloperidol induced Parkinsonism. Curr Drug Deliv 2021,18,1550-1562","journal-title":"Curr Drug Deliv"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2174\/1567201814666171130121732","volume":"15","author":"Abd-Elrasheed E.","year":"2018","unstructured":"Abd-Elrasheed E.; El-Helaly S.N.; EL-Ashmoony M.M.; Salah S.; Brain targeted intranasal zaleplon nano-emulsion: In vitro characterization and assessment of gamma aminobutyric acid levels in rabbits\u2019 brain and plasma at low and high doses. Curr Drug Deliv 2018,15,898-906","journal-title":"Curr Drug Deliv"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"Lochhead J.J.","year":"2012","unstructured":"Lochhead J.J.; Thorne R.G.; Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 2012,64(7),614-628","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1773-2247(07)50094-8","volume":"17","author":"Frans\u00e9n N.","year":"2007","unstructured":"Frans\u00e9n N.; Espef\u00e4lt Westin U.; Nystr\u00f6m C.; Bj\u00f6rk E.; The in vitro transport of dihydroergotamine across porcine nasal respiratory and olfactory mucosa and the effect of a novel powder formulation. J Drug Deliv Sci Technol 2007,17(4),267-271","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijpharm.2015.05.064","volume":"490","author":"Abdelrahman F.E.","year":"2015","unstructured":"Abdelrahman F.E.; Elsayed I.; Gad M.K.; Badr A.; Mohamed M.I.; Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm 2015,490(1-2),281-291","journal-title":"Int J Pharm"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"119776","DOI":"10.1016\/j.ijpharm.2020.119776","volume":"589","author":"Chatzitaki A.T.","year":"2020","unstructured":"Chatzitaki A.T.; Jesus S.; Karavasili C.; Andreadis D.; Fatouros D.G.; Borges O.; Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety. Int J Pharm 2020,589,119776","journal-title":"Int J Pharm"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1248\/cpb.54.1722","volume":"54","author":"Du G.","year":"2006","unstructured":"Du G.; Gao Y.; Nie S.; Pan W.; The permeation of nalmefene hydrochloride across different regions of ovine nasal mucosa. Chem Pharm Bull (Tokyo) 2006,54(12),1722-1724","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.jddst.2019.101304","volume":"54","author":"Eid H.M.","year":"2019","unstructured":"Eid H.M.; Elkomy M.H.; El Menshawe S.F.; Salem H.F.; Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: Formulation, optimization by Box-Behnken design, characterization and in vivo pharmacokinetic study. J Drug Deliv Sci Technol 2019,54,101304","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10717540802006377","volume":"15","author":"Karasulu E.","year":"2008","unstructured":"Karasulu E.; Yava\u015fo\u011flu A.; Evren\u015fanal Z.; Uyan\u0131kgil Y.; Karasulu H.Y.; Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers. Drug Deliv 2008,15(4),219-225","journal-title":"Drug Deliv"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.msec.2015.11.028","volume":"59","author":"Karavasili C.","year":"2016","unstructured":"Karavasili C.; Bouropoulos N.; Sygellou L.; Amanatiadou E.P.; Vizirianakis I.S.; Fatouros D.G.; PLGA\/DPPC\/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: In vitro, ex vivo and cytocompatibility assessment. Mater Sci Eng C 2016,59,1053-1062","journal-title":"Mater Sci Eng C"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1080\/10717544.2016.1223216","volume":"23","author":"Nour S.A.","year":"2016","unstructured":"Nour S.A.; Abdelmalak N.S.; Naguib M.J.; Rashed H.M.; Ibrahim A.B.; Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: In vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies. Drug Deliv 2016,23(9),3681-3695","journal-title":"Drug Deliv"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","volume":"48","author":"Pund S.","year":"2013","unstructured":"Pund S.; Rasve G.; Borade G.; Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci 2013,48(1-2),195-201","journal-title":"Eur J Pharm Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","volume":"7","author":"Seju U.","year":"2011","unstructured":"Seju U.; Kumar A.; Sawant K.K.; Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies. Acta Biomater 2011,7(12),4169-4176","journal-title":"Acta Biomater"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.colsurfb.2013.09.030","volume":"113","author":"Sood S.","year":"2014","unstructured":"Sood S.; Jain K.; Gowthamarajan K.; Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf B Biointerfaces 2014,113,330-337","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0168-3659(88)90043-0","volume":"8","author":"Wheatley M.A.","year":"1988","unstructured":"Wheatley M.A.; Dent J.; Wheeldon E.B.; Smith P.L.; Nasal drug delivery: An in vitro characterization of transepithelial electrical properties and fluxes in the presence or absence of enhancers. J Control Release 1988,8(2),167-177","journal-title":"J Control Release"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijpharm.2019.02.026","volume":"561","author":"Salade L.","year":"2019","unstructured":"Salade L.; Wauthoz N.; Goole J.; Amighi K.; How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods. Int J Pharm 2019,561,47-65","journal-title":"Int J Pharm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejps.2018.04.016","volume":"119","author":"Berben P.","year":"2018","unstructured":"Berben P.; Bauer-Brandl A.; Brandl M.; Faller B.; Flaten G.E.; Jacobsen A.C.; Brouwers J.; Augustijns P.; Drug permeability profiling using cell-free permeation tools: Overview and applications. Eur J Pharm Sci 2018,119,219-233","journal-title":"Eur J Pharm Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1023\/B:PHAM.0000008037.57884.11","volume":"20","author":"Rinaki E.","year":"2003","unstructured":"Rinaki E.; Valsami G.; Macheras P.; Quantitative biopharmaceutics classification system: The central role of dose\/solubility ratio. Pharm Res 2003,20(12),1917-1925","journal-title":"Pharm Res"},{"key":"ref=28","first-page":"34","volume":"8","author":"Song I.S.","year":"2017","unstructured":"Song I.S.; Choi Y.A.; Choi M.K.; Comparison of gastrointestinal permeability of caffeine, propranolol, atenolol, ofloxacin, and quinidine measured using ussing chamber system and Caco-2 cell monolayer. Mass Spectrom Lett 2017,8(2),34-38","journal-title":"Mass Spectrom Lett"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12987-017-0078-x","volume":"14","author":"Chen X.","year":"2017","unstructured":"Chen X.; Sl\u00e4ttengren T.; de Lange E.C.M.; Smith D.E.; Hammarlund-Udenaes M.; Revisiting atenolol as a low passive permeability marker. Fluids Barriers CNS 2017,14(1),30","journal-title":"Fluids Barriers CNS"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/pharmaceutics11080367","volume":"11","author":"Ladel S.","year":"2019","unstructured":"Ladel S.; Schlossbauer P.; Flamm J.; Luksch H.; Mizaikoff B.; Schindowski K.; Improved in vitro model for intranasal mucosal drug delivery: Primary olfactory and respiratory epithelial cells compared with the permanent Nasal cell line RPMI 2650. Pharmaceutics 2019,11(8),367","journal-title":"Pharmaceutics"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.foodhyd.2015.12.035","volume":"56","author":"Bhushani J.A.","year":"2016","unstructured":"Bhushani J.A.; Karthik P.; Anandharamakrishnan C.; Nanoemulsion based delivery system for improved bioaccessibility and Caco-2 cell monolayer permeability of green tea catechins. Food Hydrocoll 2016,56,372-382","journal-title":"Food Hydrocoll"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/js9803205","volume":"88","author":"Irvine J.D.","year":"1999","unstructured":"Irvine J.D.; Takahashi L.; Lockhart K.; Cheong J.; Tolan J.W.; Selick H.E.; Grove J.R. Jr.; MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J Pharm Sci 1999,88(1),28-33","journal-title":"J Pharm Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1055\/s-0031-1280367","volume":"78","author":"Shikanga E.","year":"2012","unstructured":"Shikanga E.; Hamman J.; Chen W.; Combrinck S.; Gericke N.; Viljoen A.; In vitro permeation of mesembrine alkaloids from Sceletium tortuosum across porcine buccal, sublingual, and intestinal mucosa. Planta Med 2012,78(3),260-268","journal-title":"Planta Med"},{"key":"ref=34","unstructured":"ICH. Validation of analytical procedures: Text and methodology Q2(R1). Available from:  (Accessed on: 2022 Mar 7)."},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejpb.2010.12.006","volume":"77","author":"Wahlang B.","year":"2011","unstructured":"Wahlang B.; Pawar Y.B.; Bansal A.K.; Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 2011,77(2),275-282","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1055\/a-0978-5172","volume":"85","author":"Gerber W.","year":"2019","unstructured":"Gerber W.; Steyn D.; Kotz\u00e9 A.; Svitina H.; Weldon C.; Hamman J.; Capsaicin and piperine as functional excipients for improved drug delivery across nasal epithelial models. Planta Med 2019,85,1114-1123","journal-title":"Planta Med"},{"key":"ref=37","author":"Haasbroek A.","year":"2018","unstructured":"Haasbroek A.;  Drug absorption enhancement capacities and mechanisms of action of Aloe vera gel materials 2018","journal-title":"Drug absorption enhancement capacities and mechanisms of action of Aloe vera gel materials"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/jemt.22436","volume":"77","author":"Barrios A.W.","year":"2014","unstructured":"Barrios A.W.; Sanchez Quinteiro P.; Salazar I.; The nasal cavity of the sheep and its olfactory sensory epithelium. Microsc Res Tech 2014,77(12),1052-1059","journal-title":"Microsc Res Tech"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/978-0-387-74901-3_8","author":"Deferme S.","year":"2008","unstructured":"Deferme S.; Annaert P.; Augutijns P.; In vitro screening models to assess intestinal drug absorption and metabolism. Drug absorption studies: In situ, in vitro and in silico models, 2008,182-215","journal-title":"Drug absorption studies: In situ, in vitro and in silico models,"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10928-008-9086-4","volume":"35","author":"Palumbo P.","year":"2008","unstructured":"Palumbo P.; Picchini U.; Beck B.; van Gelder J.; Delbar N.; DeGaetano A.; A general approach to the apparent permeability index. J Pharmacokinet Pharmacodyn 2008,35(2),235-248","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ptr.2563","volume":"23","author":"Hansen T.S.","year":"2009","unstructured":"Hansen T.S.; Nilsen O.G.; Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells. Phytother Res 2009,23(1),86-91 www.interscience.wiley.com","journal-title":"Phytother Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"107131","DOI":"10.1016\/j.vascn.2021.107131","volume":"113","author":"Gerber W.","year":"2022","unstructured":"Gerber W.; Svitina H.; Steyn D.; Peterson B.; Kotz\u00e9 A.; Weldon C.; Hamman J.H.; Comparison of RPMI 2650 cell layers and excised sheep nasal epithelial tissues in terms of nasal drug delivery and immunocytochemistry properties. J Pharmacol Toxicol Methods 2022,113,107131","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"Crowe T.P.","year":"2018","unstructured":"Crowe T.P.; Greenlee M.H.W.; Kanthasamy A.G.; Hsu W.H.; Mechanism of intranasal drug delivery directly to the brain. Life Sci 2018,195,44-52","journal-title":"Life Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4155\/tde.14.41","volume":"5","author":"Djupesland P.G.","year":"2014","unstructured":"Djupesland P.G.; Messina J.C.; Mahmoud R.A.; The nasal approach to delivering treatment for brain diseases: An anatomic, physiologic, and delivery technology overview. Ther Deliv 2014,5(6),709-733","journal-title":"Ther Deliv"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","volume":"12","author":"Keller L.A.","year":"2022","unstructured":"Keller L.A.; Merkel O.; Popp A.; Intranasal drug delivery: Opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res 2022,12(4),735-757","journal-title":"Drug Deliv Transl Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"Illum L.","year":"2003","unstructured":"Illum L.; Nasal drug delivery - Possibilities, problems and solutions. J Control Release 2003,87,187-198","journal-title":"J Control Release"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/jbb.S2-001","volume":"01","author":"Fortuna A.","year":"2011","unstructured":"Fortuna A.; Alves G.; Falc\u00e3o A.; In vitro and in vivo relevance of the P-glycoprotein probe substrates in drug discovery and development: Focus on rhodamine 123, digoxin and talinolol. J Bioequivalence Availab 2011,01(02),1-23","journal-title":"J Bioequivalence Availab"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-12-814001-7.00004-4","author":"Sharma B.","year":"2019","unstructured":"Sharma B.; Luhach K.; Kulkarni G.T.;  Brain targeted Drug Delivery Systems: A Focus on Nanotechnology and Nanoparticles 2019,53-101","journal-title":"Brain targeted Drug Delivery Systems: A Focus on Nanotechnology and Nanoparticles"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1071\/BI9700447","volume":"23","author":"E Kratzing J.","year":"1970","unstructured":"E Kratzing J.; The olfactory mucosa of the sheep. Aust J Biol Sci 1970,23(2),447-458","journal-title":"Aust J Biol Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1292\/jvms.13-0436","volume":"76","author":"Ibrahim D.","year":"2014","unstructured":"Ibrahim D.; Nakamuta N.; Taniguchi K.; Yamamoto Y.; Taniguchi K.; Histological and lectin histochemical studies on the olfactory and respiratory mucosae of the sheep. J Vet Med Sci 2014,76(3),339-346","journal-title":"J Vet Med Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.aanat.2010.07.004","volume":"192","author":"Kavoi B.","year":"2010","unstructured":"Kavoi B.; Makanya A.; Hassanali J.; Carlsson H.E.; Kiama S.; Comparative functional structure of the olfactory mucosa in the domestic dog and sheep. Ann Anat 2010,192(5),329-337","journal-title":"Ann Anat"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666221214105836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211939\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666221214105836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T12:57:15Z","timestamp":1698843435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211939\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201820666221214105836","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}